Abstract
Protein degradation is essential for maintaining cellular homeostasis. The proteasome is the central enzyme responsible for non-lysosomal protein degradation in eukaryotic cells. Although proteasome assembly is not yet completely understood, a number of cofactors required for proper assembly and maturation have been identified. Ump is a short-lived maturation factor required for the efficient biogenesis of the 20S proteasome. Upon the association of the two precursor complexes, Ump is encased and is rapidly degraded after the proteolytic sites in the interior of the nascent proteasome are activated. In order to further understand the mechanisms behind proteasomal maturation, we expressed and purified yeast Ump in E. coli for biophysical and structural analysis.
We show that recombinant Ump is purified as a mixture of different oligomeric species and that oligomerization is mediated by intermolecular disulfide bond formation involving the only cysteine residue present in the protein. Furthermore, a combination of bioinformatic, biochemical and structural analysis revealed that Ump shows characteristics of an intrinsically disordered protein, which might become structured only upon interaction with the proteasome subunits.
Keywords: Circular dichroism, protein structure, dynamic light scattering, intrinsically disordered
Introduction
The 26S proteasome is the central player in the degradation of proteins by the ubiquitin-mediated proteolytic pathway in eukaryotic cells [1, 2]. This ATP-dependent multimeric protease complex is composed of the catalytic core particle (CP), named 20S proteasome that can be capped in one or both ends by the 19S regulatory particle. Recently, the topology of the 26S proteasome was revealed by electron microscopy studies [3, 4, 5]. Earlier crystallographic studies had provided a detailed knowledge of the subunit arrangement of the 20S CP [6, 7]. The eukaryotic CP is composed of 14 distinct subunits, seven α and seven β subunits, organized in four stacked heptameric rings with an α1-7β1-7β1-7α1-7 arrangement. The proteolytic sites are sequestered in the internal part of the chamber formed by the two β rings [6, 7, 8]. The active 20S CP is the result of a highly coordinated assembly process involving several conserved and specific chaperones. The dimeric chaperones Pba1-Pba2 and Pba3-Pba4 (‘Pba’, ‘proteasome biogenesis-associated’; also known as ‘Poc1-Poc4’ for ‘Proteasome chaperone’,) are thought to promote assembly of rings composed of seven α subunits, the platform for binding of the β subunits [9]. Ump1 (ubiquitin-mediated proteolysis), originally identified in Saccharomyces cerevisiae, was the first proteasome-specific assembly chaperone to be described [10]. Ump1, a ∼17 kDa short-lived protein, is found in precursor (or 15S) complexes called half-proteasomes that contain unprocessed β subunits [10, 11]. Besides Ump1, the 15S complexes contain all CP subunits, except for β7, and the chaperone Pba1-Pba2 [12, 13, –14]. Dimerization of two such complexes is triggered by incorporation of β7, whose C-terminal extension reaches out into the other half to stabilize the newly formed 20S particle [14, 15]. Ump1 is encased during precursor dimerization and is important for autocatalytic processing of β1, β2 and β5. Upon maturation of the active sites, Ump1 is rapidly degraded as the first substrate of the newly formed 20S CP [10, 16].
S. cerevisiae Ump1 is a conserved protein found in all eukaryotes [11]. The human ortholog, hUmp1, was shown to perform similar functions to its S. cerevisiae counterpart in proteasome biogenesis [17, 18, 19, 20, 21]. In contrast to yeast Ump1, hUmp1 appears to be essential for viability, as suggested by siRNA knockdown experiments [19, 20]. It was reported that hUmp1 binds to membranes leading to precursor proteasome assembly at the endoplasmic reticulum [22]. Studies in S. cerevisiae suggested that Ump1-containing precursor complexes are imported into the nucleus where the assembly of nuclear proteasomes is completed [23].
At present, no three-dimensional structure of Ump1 proteins is available, although there is some information on their functional domains. The C-terminal region, encompassing residues 51-147 of yeast Ump1 or 61-141 of human Ump1, is required and sufficient for interaction with proteasome precursor complexes. Residues 68 to 72 of hUmp1 are essential for this interaction [17]. By contrast, the region containing the first 50 amino acid residues of Ump1 is neither sufficient nor required for incorporation of Ump1 into precursor complexes [17]. These Ump1 regions are likely to operate by interacting with distinct substructures of different proteasome subunits. Indeed, hUmp1 binds directly to several α and β subunits and associates with α rings in vitro [19, 22, 24]. In line with this finding, hUmp1 appears to be essential for the binding of the β2 subunit to α ring precursor complexes, and therefore for the initiation and assembly of β rings [24]. In vitro experiments showed that hUmp1 binds directly to the β5 subunit [24]. Interestingly, the yeast β5 propeptide becomes dispensable in cells lacking Ump1, but is essential for viability in its presence [10, 25]. In vivo depletion of hUmp1 by siRNA experiments, however, prevented the incorporation of β5 into nascent proteasome precursor complexes [19].
Here we report the biochemical and biophysical characterization of recombinant yeast Ump1. Ump1 purified as a heterogeneous mixture of monomers and dimers. Dimer formation is mediated by Cys115. Mutation of this single cysteine to serine abolished dimer formation leading to preparations enriched in monomeric Ump1. Nevertheless, the purified mutated monomers were conformationally too heterogeneous to crystallize. A comparative biophysical analysis showed that Ump1 displays characteristics of a natively disordered protein. This biophysical property is independent of the oligomeric state of the protein and suggests that Ump1 structure might be stabilized upon interaction with proteasomal subunits and concomitant incorporation into proteasomal precursor complexes.
Materials and methods
Protein expression and purification
The plasmid pJD492-UMP1 was designed to express UMP1-6xHis yielding a non-cleavable C-terminally 6His-tagged version of S. cerevisiae Ump1. A PCR fragment, containing the nucleotide sequence of the complete UMP1 ORF, was cloned into pET11a using XbaI and BamHI restriction sites. The plasmid encodes the full-length Ump1 followed by the additional amino acid sequence GYHHHHHH. This plasmid was used as a template for construction of the mutant plasmid pJD492-UMP1-C115S by PCR. The following primers were synthesized to introduce the mutated sequence: 5′-CTA CTG AAC AAA GAG TCC AGC ATC GAT TGG GAG-3′ and 5′-CTC CCA ATC GAT GCT GGA CTC TTT GTT CAG TAG -3′ (bold represents mutation site). The mutation was confirmed by sequencing (Eurofins). Both plasmids encoding the 6His-tagged versions of yeast Ump1 under the control of a T7 promotor were used to transform E. coli BL21 CodonPlus (Stratagene) competent cells.
For expression of S. cerevisiae Ump1 and Ump1-C115S, E. coli BL21 CodonPlus (Stratagene) transformed with the expression plasmids were grown in lysogeny broth (LB) medium containing ampicillin and chloramphenicol (final concentrations of 100 µg/mL and 34 µg/mL, respectively), and incubated at 37°C until OD600 reached approximately 0.3. The incubation temperature was reduced to 24 °C, before induction of protein expression by addition of IPTG (Biosynth) to a final concentration of 2 mM. Cells were harvested by centrifugation 4 h after induction and the cell pellet from each liter of culture was resuspended in 20 mL of lysis buffer (0.1% (v/v) Tween 20, 300 mM NaCl, 10 mM imidazole in PBS (phosphate buffered saline – 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 4 mM KH2PO4, pH 8.0) supplemented with 50 µg/mL of lysozyme and stored at -20 °C. Upon thawing, complete EDTA-free protease inhibitor cocktail (Roche), 5 µg/mL DNAse I and 10 mM MgCl2 (final concentration) were added to the cell lysate, which was centrifuged and the supernatant loaded onto a 5 mL HisTrap column (GE Healthcare) previously equilibrated with buffer A (20 mM sodium phosphate pH 8.0, 500 mM NaCl and 10 mM imidazole). The column was washed with 10 column volumes of buffer A and bound proteins were eluted with 100 mM imidazole in buffer A.
Fractions containing recombinant Ump1 were pooled, desalted on a HiPrep 26/10 column (GE Healthcare), previously equilibrated in 50 mM Tris-HCl pH 7.5. The desalted Ump1 fraction was further purified on an anion-exchange column (MonoQ; GE Healthcare), using a linear 0 to 1 M NaCl gradient in 50 mM Tris-HCl pH 7.5. The oligomeric state of the protein was verified by size-exclusion chromatography on a Superdex 75 column (GE Healthcare) equilibrated with 50 mM Tris pH 7.5, 100 mM NaCl. The column was calibrated using aprotinin (6.5 kDa), ribonuclease A (13.7 kDa), chymotrypsinogen (25.0 kDa), and ovalbumin (43.0 kDa) as standards. The void volume (Vo) was calculated by determining the elution volume of dextran blue. The partition coefficient (Kav) for each protein was obtained with the following equation: Kav=(Ve-Vo)/(Vt-Vo), where Ve is the elution volume and Vt is the total bed volume. A standard calibration curve of Kav versus log(MW) was used to calculate the apparent molecular mass of the distinct recombinant Ump1 molecular species. The Stokes radius (Rs) for the globular protein standards was calculated with the equation Log(Rs) = -(0.204±0.023)+(0.357±0.005)•log(MW) [26]. These values were used to create a calibration curve (1000/Ve vs. Rs), which allowed the determination of the Rs for the distinct Ump1 molecular species. For plotting the theoretical relationship between Rs and MW for proteins in native (Native), natively unfolded pre-molten globule (nu-PMG) and urea-unfolded (un) conformations, the following equations were used: log(RsNative) =-(0.204 ±0.023)+(0.357 ± 0.005)•log(MW); log(Rsnu-PMG) =-(0.239 ±0.055)+(0.403 ± 0.012)•log(MW) and log(Rsun) =-(0.723 ±0.033)+(0.543 ± 0.007)•log(MW) [26].
Dynamic Light-Scattering (DLS) measurements
Hydrodynamic radius (RH) measurements were made at 25°C with a Zetasizer Nano ZS DLS apparatus (Malvern Instruments). A sample (50 µl) containing 0.5 mg/ml protein in 50 mM Tris-HCl pH 7.5, 100 mM NaCl was centrifuged and filtered through a 0.2 µm filter to remove suspended particles, and placed in a quartz cuvette. Particle diffusion coefficients were calculated from auto-correlated light intensity data, and converted to RH with the Stokes-Einstein equation (D t = k B T/6πηR H, where k B is the Boltzmann constant; T is temperature in Kelvin; η is solvent viscosity; and R H is the hydrodynamic radius of the protein). A histogram of the percentage of the scattering mass versus RH was calculated using DTS (nano) 6.01 software (Malvern Instruments). Data represent an average of 3 measurements for each sample.
Limited proteolysis
Limited proteolysis assays were performed by incubating the purified recombinant protein with trypsin at a ratio of 1000:1 (w/w) in 50 mM Tris-HCl pH 8.0 and 100 mM NaCl, at 37°C. Aliquots were collected at specific time points (0 and 30 min) and reactions were stopped by incubation at 95°C for 5 minutes in standard sample buffer without or with 10 mM DTT. The cleavage products were separated by SDS-PAGE (17.5% acrylamide gel), transferred onto PVDF membrane, and analysed by Edman degradation.
For analysis of the secondary structure content of the N- and C- terminal peptides, recombinant Ump1-C115S was treated with trypsin for 30 min and the solution obtained after limited proteolysis was applied to a 1 mL HisTrap column (GE Healthcare) previously equilibrated with buffer A, and the unbound N-terminal fragment collected by washing with 2 column volumes of buffer A. The bound proteins were eluted with 100 mM imidazole in buffer A and contained a mixture of full-length Ump1 and the His-tagged C-terminal peptide. The purified N-terminal fragment was dialysed against 50 mM Tris-HCl pH 7.5, 100 mM NaCl, concentrated to 5 mg/mL and used for CD analysis.
Circular dicroism
The secondary structure content of full-length Ump1 was assessed by far-UV circular dichroism (CD) spectroscopy. Measurements were performed on a Jasco J-815 spectrometer equipped with a Peltier-controlled thermostated cell support. Ump1 solutions were 0.1 mg/ml in 50 mM Tris-HCl pH 7.5, 100 mM NaCl with or without 1 mM DTT (freshly prepared and incubated for 1 h at 4°C). CD spectra were acquired at 25°C, with the instrument set up to 2 nm bandwidth, 1 s response, 200 nm/min scanning speed and 10 accumulations. Spectra were deconvoluted with CDNN 2.1 [27]. Thermal unfolding was performed by raising the temperature at a rate of 1 °C/min, between 25 and 90°C, while monitoring the CD signal at 205 nm. The unfolded protein fraction was calculated by normalizing the CD signal variation.
For analysis of the secondary structure content of Ump1-C115S and N-terminal fragment by far-UV CD in buffer without DTT and low NaCl concentration, the proteins were diluted to a final concentration of 0.1 mg/mL in 1 mM Tris-HCl pH 7.5, 2 mM NaCl, and measurements were performed at 20°C on a Jasco J-815 spectrometer fitted with a Peltier temperature controller. Spectra were acquired between 190 and 260 nm, set up to 1 nm bandwidth, 1 s response, 500 nm/min scanning speed and 3 accumulations. Each spectrum was the average of two scans corrected for buffer background. The spectra were deconvoluted with the CONTIN program using the online software Dichroweb [28, 29].
Analysis of primary sequence and prediction of disorder
Prediction of disorder for Ump1 was performed on multiple sequence alignments with RONN (http://www.bioinformatics.nl/∼berndb/ronn.html) that uses a modification of the Bio-Basis Function Neural Network (BBFNN) [30] and Fold Index [31], based on the algorithm of Uversky and coworkers [32]. For comparison with other available disorder prediction servers yeast Ump1 sequence was also analysed with the Meta Protein DisOrder prediction System (http://prdos.hgc.jp/cgi-bin/meta/top.cgi), an online webserver that predicts the disorder tendency of each residue resorting to the prediction results of the seven independent disorder predictors [33] (Figure S2).
Results
Ump1 purified under non-reducing conditions self-assembles into oligomeric species
Yeast Ump1, expressed in E. coli and containing a C-terminal 6His tag, was efficiently purified by metal affinity chromatography. In a subsequent ion-exchange chromatography, two Ump1-containing peaks were eluted with different NaCl concentrations (Figure 1A). This elution profile and isoelectric focusing (data not shown), indicated that recombinant Ump1 purified by metal affinity chromatography was heterogeneous and contained at least two differently charged species. Analysis by SDS-PAGE showed that, under reducing conditions, the proteins eluting in the different peaks after ion exchange chromatography were indistinguishable (Figure 1B). However, when no reducing agent was added, the protein eluting with lower NaCl concentration migrated faster (apparent MW 18 kDa corresponding to the predicted value for the tagged protein, and from here on referred to as monomer, Figure 1) than the protein eluted with higher NaCl concentrations (apparent MW 36 kDa and from here on referred to as dimer, Figure 1). Taken together these data indicated that Ump1 was purified as a mixture of presumably monomers and dimers (under non-reducing conditions), and that self-association was mediated by formation of an intermolecular disulfide bond.
A cysteine residue at position 115 is involved in Ump1 oligomerization
Analysis of the Ump1 amino acid sequence (Figure 2) shows that disulfide bond formation likely involves the single non-conserved cysteine residue at position 115. Interestingly, previous work with the recombinant human Ump1 ortholog revealed that it also self-assembles and that oligomerization is likely to be mediated by a cysteine residue (Cys37) located in the N-terminal region of the protein [34].
Analysis of the two peaks obtained by size exclusion chromatography (Figure 3) confirmed that the two Ump1 fractions correspond to different oligomeric states of the recombinant protein. Purification under reducing conditions (addition of 1-5 mM DTT in all chromatography and protein storage buffers) increased the yield of the Ump1 species with lower molecular weight (monomer, data not shown), but this protein slowly converted to a mixture of the two forms, rendering this sample too heterogeneous for further biophysical and structural studies.
In an attempt to obtain homogeneous protein, and to confirm the implication of cysteine 115 in Ump1 dimerization, we mutated this residue to a serine. The purified Ump1-C115S mutant was analyzed by SDS-PAGE (Figure 1B), size-exclusion chromatography (Figure 3), and DLS (Table 1) and compared to wild-type Ump1 purified under non-reducing conditions. The mutant protein purified as a single peak in the ion-exchange column (data not shown) and in the analytical size exclusion chromatography (Figure 3A). The C115S mutant eluted with a lower apparent molecular weight than that of the wild-type disulfide-bonded Ump1 dimer, supporting the hypothesis that Cys115 is responsible for the oligomerization of wild-type Ump1. However, both Ump1 species eluted with apparent molecular masses (40 and 65 kDa for the lower and higher molecular mass Ump1 species, respectively) that are larger than the theoretical values for monomeric (18 kDa) or dimeric (36 kDa) tagged Ump1. The apparent molecular mass determined for the lower molecular weight species, is larger than a monomer and approaches the value expected for a non-covalently associated dimer. Similarly, the higher molecular mass species displays an intermediate size, closer to a tetramer. Since this atypical mobility is a characteristic of intrinsically disordered proteins [37], one hypothesis to support these results is that the purified Ump1 species could represent a mixture of monomers (with identical elution profiles to Ump1-C115S) and covalently associated dimers (wild-type Ump1 higher molecular mass species) with non-compact elongated shapes, resulting in anomalous migration in size-exclusion chromatography.
Table 1.
Ump1 species | Polydispersity index | Stokes radius (Å) | Calculated molecular mass (kDa) | Percentage of scattering volume in solution |
---|---|---|---|---|
Ump1 wild-type monomer | 0.3 | 18.1 | 13.5 | 15.1% |
20.9 | 18.9 | 17.4% | ||
24.2 | 26.6 | 16.4% | ||
Ump1 wild-type dimer | 0.3 | 24.2 | 26.6 | 15.5% |
28 | 37.4 | 17.4% | ||
32.5 | 53.1 | 16.1% | ||
Ump1-C115S monomer | 0.2 | 20.9 | 18.9 | 15.7% |
24.2 | 26.6 | 16.9% | ||
28.1 | 39 | 15.4% |
The calculation of the Stokes radii, which was based upon the values of a standard calibration curve (Figure 3) revealed values of 27 Å and 34 Å for the lower and higher molecular mass species, respectively. To obtain another estimate of the hydrodynamic dimensions of the protein in solution, the diffusion coefficient was measured by dynamic light scattering (DLS). All samples have high polydispersity indices, and show a heterogeneous distribution of particles with different molecular sizes in solution (Table 1), with ∼50% of the scattering volume attributed to particles ranging between 18 and 24 Å for the monomeric wild-type Ump1, and between 24 and 32 Å for dimeric Ump1. These data reinforce the view that both recombinant wild-type Ump1 and the C115S mutant are highly heterogeneous in solution.
The logarithmic plot of these calculated Rs values versus the molecular masses of the corresponding monomeric and dimeric Ump1 variants indicates that these proteins do not behave as natively folded globular proteins in solution, and fall very close to the plot representing the behaviour of molecules with a natively unfolded molten globule conformation (Figure 3B). All results indicate that the Rs for the recombinantly expressed Ump1 molecular species are significantly larger than expected for a globular protein of similar molecular mass. Despite the current experimental evidence, however, it cannot be excluded that non-covalent oligomerization is a reason for the higher-than-predicted apparent molecular masses of the monomeric and dimeric Ump1 species in solution. The data suggest that this protein is at least partially unfolded and alternates between multiple extended conformations with variable hydrodynamic radius. In addition, the C115S mutation, although eliminating the heterogeneity attributed to the formation of covalently associated wild-type Ump1 oligomers, did not prevent the appearance of molecules with variable sizes as clearly seen in the DLS data (Table 1), and likely attributable to conformational variation between slightly more compact and extended conformations.
Recombinant Ump1 is partially disordered in solution
In agreement with the hypothesis that Ump1 is at least partially unfolded, leading to the apparently higher hydrodynamic radius of the different molecular species of recombinant Ump1, analysis of its primary sequence shows that 33% of its amino acid residues are predicted to be disordered (Figure 2). These residues are mainly distributed in the N-terminal half of the protein, comprising amino acids 12-38 and 47-63 (Figure 2 and S2). The prediction of disorder extends to the sequences of Ump1 orthologs, indicating that the regions predicted to be partially unfolded might have a functional significance.
Circular dichroism (CD) spectra were recorded to compare the secondary structure content of the wild-type and mutant Ump1 oligomeric species, and thus confirm its folding state. The CD spectra for all proteins (monomeric and dimeric wild-type Ump1, as well as Ump1-C115S mutant) exhibit isodichroic curves, with a minimum at 201 nm and a shoulder around 222 nm (Figure 4A). The negative peak is characteristic of random coil structures. Spectral similarity indicates similar secondary structure content in all Ump1 preparations. These results provide evidence for the presence of structured and unstructured regions in Ump1, in agreement with the disorder predictions. The secondary structure content, however, is not significantly affected by the oligomeric state of the protein or by the C115S mutation.
To gain complementary insight into the folding properties of Ump1, we performed thermal denaturation assays of monomeric and dimeric wild-type versions (in the presence or absence of DTT) as well as of the C115S mutant, while simultaneously monitoring the CD signal at 205 nm (Figure 4B). Interestingly, all preparations of wild-type Ump1 exhibit a very gradual – and almost constant – CD signal variation with temperature, from 25 to 90°C. This is unlike the typical behaviour of small, single domain folded globular proteins, where the unfolding is highly cooperative and occurs in a very narrow temperature range. Also, even at 90°C, Ump1 does not seem to be fully denatured, as seen by the fact that the CD signal does not plateau at high temperature. This behaviour is what one would expect from a protein harbouring unstructured regions, since the inability to maintain a compact hydrophobic core would, (i) hinder the establishment of the interaction network responsible for folding cooperativity, and (ii) substantially increase the conformational entropy and therefore increase the resistance to full unfolding. The C115S mutant exhibits higher unfolding cooperativity, but the overall considerations made for the wild-type still apply.
Limited proteolysis experiments shows that Ump1 is cleaved by trypsin at Arg84 (Figure S1), leaving an N-terminal fragment that includes most of the region predicted to be unstructured as well as the conserved HPLE sequence (Figure 2) required for proteasome interaction [17]. The CD spectra from this Ump1 N-terminal proteolytic fragment confirm that, in accordance with the theoretical disorder predictions (Figure 2 and S2), the N-terminal region is largely unstructured (Figure 5). Spectral deconvolution of the full-length Ump1-C115S reveals that it contains 19% α-helices, 20% β-strands, 19% turns and around 42% random coil. The N-terminal segment is predominantly composed of random coil (∼50%), with 24% of β-strands, 22% turns and a negligible amount of α-helices (∼1%). The C-terminal spectrum, obtained by subtracting the N-terminal Ump1 spectrum from that of Ump1-C115S, provides an estimate of the secondary structure content of the C-terminal region and suggests that this region has a significant secondary structure content with a relatively lower percentage of coil regions (27% coil, 17% α-helices, 37% β-strands and 19% turns).
Discussion
Biochemical characterization of S. cerevisiae Ump1 was performed using a variety of techniques. The results obtained by size exclusion chromatography and CD, together with amino acid sequence analysis, show that recombinant Ump1 is a natively unfolded protein. Accurate identification of these disordered regions in proteins, which confer conformational heterogeneity to the samples but are often mediators of protein-protein interactions, is crucial for structural and functional studies.
The recombinantly expressed and purified Ump1 consists of a heterogeneous mixture of molecules with variable isoelectric points and hydrodynamic radii. In particular, the non-conserved single cysteine at position 115 is partly responsible for this heterogeneity leading to Ump1 self-assembly by disulfide-bond formation. Conceivably, dimerization may play a role in proteasome biogenesis, a process that could be modulated by the local redox state of the cell. Indeed, disulfide-mediated virion assembly in the cytosol catalyzed by virus-encoded redox-regulated proteins has been previously demonstrated [39]. However, the lack of evolutionary conservation of this cysteine residue (Figure 2) may indicate that cysteine-mediated dimerization might not have a key role in Ump1 function in vivo. Mutation of Cys115 to serine eliminates the formation of covalently associated Ump1 oligomers, but the anomalously large Stokes radius of this monomeric form suggests that the protein is not globular and its conformation is predicted to be a natively unfolded molten globule.
The intrinsic disorder of Ump1 is supported by CD analysis of the secondary structure content, which indicated that ∼42% of its structure is dominated by a random coil conformation (Figure 4A, Figure 5). These data are in agreement with a theoretical prediction of disorder, particularly relevant in the N-terminal half of the protein (Figure 2, Figure S2), which was shown to be ∼50% random coil (Figure 5). Moreover, the low unfolding cooperativity and high stability of Ump1 towards unfolding by temperature (Figure 4B) constitute additional fingerprints for structurally disordered proteins. In this context, it is worth noting that the Ump1 region 51-147 starting at the conserved HPLE motif, which is predicted to be unstructured (Figure 2), is sufficient for interaction with proteasome precursor complexes [17]. The flexibility of its N-terminal domain may give the protein the ability to bind multiple targets during proteasome assembly. One possibility is that the N-terminal region of Ump1 engages in interactions with components of a second 15S complex during their dimerization [16]. Another important aspect of a lack of regular secondary structure is that it might provide Ump1 with the capability to adjust to steric restrictions upon enclosure in the newly formed proteasome following dimerization of 15S precursor complexes [13].
There is a currently growing awareness of the fundamental importance of disordered regions of proteins in many biological and pathological processes [38, 40]. These regions, characterized by the absence of a well-defined three-dimensional structure and displaying structural flexibility, are highly abundant in eukaryotic proteomes. These features are proposed to provide a functional advantage to proteins by enabling them to interact with multiple binding partners and to behave as intracellular hubs [41]. The inherent plasticity of these intrinsically disordered regions allows them to play fundamental roles in macromolecular recognition and assembly, and to be active players in molecular events such as intracellular signalling, which require transient interactions and shuttling between different macromolecular assemblies.
Ump1 mechanism of action is not yet completely understood and its known interaction partners are limited to some proteasome subunits. Ump1 was proposed to provide a checkpoint that prevents early dimerization of precursor complexes until their assembly is completed [13]. The propeptides of proteasome subunits β5 and β6, as well as the β7 C-terminal extension might contribute to overcome this checkpoint after incorporation of β7 by displacing Ump1 or changing its conformation [10, 13, 16]. Structural flexibility of Ump1 might be a key characteristic enabling these adjustments.
Characterization of Ump1, a key factor in proteasome biogenesis, may open a window of opportunity for the development of new proteasome inhibitors. Since the proteasome has been shown to be a suitable target in cancer therapy [42], development of alternative or additional proteasome inhibitors that interfere with proteasome assembly might contribute enormously to cancer treatment.
Supplementary Material
Acknowledgements
We thank Frederico Silva (UP3 - Protein Production and Purification Unit, IBMC) for technical support during protein purification, Reinhard Mentele (MPI für Biochemie, Martinsried) for N-terminal sequencing of recombinant Ump1 and Zsusza Sárkány for support with analysis of DLS data. This work was supported by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Competitiveness Programme (COMPETE), by national funds through Fundação para a Ciência e a Tecnologia (Portugal) under projects POCTI/BME/47604/2002, POCI/BIA-PRO/58638/2004, FCOMP-01- 0124-FEDER-022718 (PEst-C/SAU/LA0002/2011) and by the strategic Grant PEst-OE/EQB/LA0004/2011 (through CMG at ITQB Laboratório Associado). IA acknowledges the financial support from FCT through Ciência 2008 Programme. HMB acknowledges a PhD fellowship from FCT (SFRH/BD/31126/2006).
Competing Interests
The authors have declared that no competing interests exist.
References
- 1.Marques AJ, Palanimurugan R, Matias AC, Ramos PC, Dohmen RJ (2009) Catalytic mechanism and assembly of the proteasome. Chem Rev 109: 1509–1536 [DOI] [PubMed] [Google Scholar]
- 2.Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477–513 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, et al (2012) Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc Natl Acad Sci U S A 109: 1380–1387 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Beck F, Unverdorben P, Bohn S, Schweitzer A, Pfeifer G, et al (2012) Near-atomic resolution structural model of the yeast 26S proteasome. Proc Natl Acad Sci U S A 109: 14870–14875 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, et al (2012) Complete subunit architecture of the proteasome regulatory particle. Nature 482: 186–191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, et al (1997) Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386: 463–471 [DOI] [PubMed] [Google Scholar]
- 7.Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, et al (2002) The structure of the mammalian 20S proteasome at 2.75 Å resolution. Structure 10: 609–618 [DOI] [PubMed] [Google Scholar]
- 8.Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, et al (1995) Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 268: 533–539 [DOI] [PubMed] [Google Scholar]
- 9.Kusmierczyk AR, Kunjappu MJ, Kim RY, Hochstrasser M (2011) A conserved 20S proteasome assembly factor requires a C-terminal HbYX motif for proteasomal precursor binding. Nat Struct Mol Biol 18: 622–629 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ramos PC, Hockendorff J, Johnson ES, Varshavsky A, Dohmen RJ (1998) Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell 92: 489–499 [DOI] [PubMed] [Google Scholar]
- 11.Ramos PC, Dohmen RJ (2008) PACemakers of proteasome core particle assembly. Structure 16: 1296–1304 [DOI] [PubMed] [Google Scholar]
- 12.Le Tallec B, Barrault MB, Courbeyrette R, Guerois R, Marsolier-Kergoat MC, et al (2007) 20S proteasome assembly is orchestrated by two distinct pairs of chaperones in yeast and in mammals. Mol Cell 27: 660–674 [DOI] [PubMed] [Google Scholar]
- 13.Li X, Kusmierczyk AR, Wong P, Emili A, Hochstrasser M (2007) Subunit appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint. Embo J 26: 2339–2349 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Marques AJ, Glanemann C, Ramos PC, Dohmen RJ (2007) The C-terminal extension of the ß7 subunit and activator complexes stabilize nascent 20S proteasomes and promote their maturation. J Biol Chem 282: 34869–34876 [DOI] [PubMed] [Google Scholar]
- 15.Ramos PC, Marques AJ, London MK, Dohmen RJ (2004) Role of C-terminal extensions of subunits ß2 and ß7 in assembly and activity of eukaryotic proteasomes. J Biol Chem 279: 14323–14330 [DOI] [PubMed] [Google Scholar]
- 16.Matias AC, Ramos PC, Dohmen RJ (2010) Chaperone-assisted assembly of the proteasome core particle. Biochem Soc Trans 38: 29–33 [DOI] [PubMed] [Google Scholar]
- 17.Burri L, Hockendorff J, Boehm U, Klamp T, Dohmen RJ, et al (2000) Identification and characterization of a mammalian protein interacting with 20S proteasome precursors. Proc Natl Acad Sci U S A 97: 10348–10353 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Griffin TA, Slack JP, McCluskey TS, Monaco JJ, Colbert RA (2000) Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. Mol Cell Biol Res Commun 3: 212–217 [DOI] [PubMed] [Google Scholar]
- 19.Heink S, Ludwig D, Kloetzel PM, Kruger E (2005) IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A 102: 9241–9246 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hirano Y, Hendil KB, Yashiroda H, Iemura S, Nagane R, et al (2005) A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes. Nature 437: 1381–1385 [DOI] [PubMed] [Google Scholar]
- 21.Witt E, Zantopf D, Schmidt M, Kraft R, Kloetzel PM, et al (2000) Characterisation of the newly identified human Ump1 homologue POMP and analysis of LMP7(ß5i) incorporation into 20S proteasomes. J Mol Biol 301: 1–9 [DOI] [PubMed] [Google Scholar]
- 22.Fricke B, Heink S, Steffen J, Kloetzel PM, Kruger E (2007) The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep 8: 1170–1175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lehmann A, Janek K, Braun B, Kloetzel PM, Enenkel C (2002) 20S proteasomes are imported as precursor complexes into the nucleus of yeast. J Mol Biol 317: 401–413 [DOI] [PubMed] [Google Scholar]
- 24.Hirano Y, Kaneko T, Okamoto K, Bai M, Yashiroda H, et al (2008) Dissecting ß-ring assembly pathway of the mammalian 20S proteasome. Embo J 27: 2204–2213 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chen P, Hochstrasser M (1996) Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 86: 961–972 [DOI] [PubMed] [Google Scholar]
- 26.Permyakov SE, Millett IS, Doniach S, Permyakov EA, Uversky VN (2003) Natively unfolded C-terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin. Proteins 53: 855–862 [DOI] [PubMed] [Google Scholar]
- 27.Bohm G, Muhr R, Jaenicke R (1992) Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 5: 191–195 [DOI] [PubMed] [Google Scholar]
- 28.Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392–400 [DOI] [PubMed] [Google Scholar]
- 29.Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32: W668–673 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Yang ZR, Thomson R, McNeil P, Esnouf RM (2005) RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 21: 3369–3376 [DOI] [PubMed] [Google Scholar]
- 31.Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, et al (2005) FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435–3438 [DOI] [PubMed] [Google Scholar]
- 32.Uversky VN, Gillespie JR, Fink AL (2000) Why are “natively unfolded” proteins unstructured under physiologic conditions?. Proteins 41: 415–427 [DOI] [PubMed] [Google Scholar]
- 33.Ishida T, Kinoshita K (2008) Prediction of disordered regions in proteins based on the meta approach. Bioinformatics 24: 1344–1348 [DOI] [PubMed] [Google Scholar]
- 34.Hoefer MM, Boneberg EM, Grotegut S, Kusch J, Illges H (2006) Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation. Int J Biol Macromol 38: 259–267 [DOI] [PubMed] [Google Scholar]
- 35.Bond CS, Schuttelkopf AW (2009) ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. Acta Crystallogr D Biol Crystallogr 65: 510–512 [DOI] [PubMed] [Google Scholar]
- 36.Tcherkasskaya O, Uversky VN (2001) Denatured collapsed states in protein folding: example of apomyoglobin. Proteins 44: 244–254 [DOI] [PubMed] [Google Scholar]
- 37.Receveur-Brechot V, Bourhis JM, Uversky VN, Canard B, Longhi S (2006) Assessing protein disorder and induced folding. Proteins 62: 24–45 [DOI] [PubMed] [Google Scholar]
- 38.Uversky VN (2010) The mysterious unfoldome: structureless, underappreciated, yet vital part of any given proteome. J Biomed Biotechnol 2010: 568068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Li PP, Nakanishi A, Clark SW, Kasamatsu H (2002) Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm. Proc Natl Acad Sci U S A 99: 1353–1358 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Uversky VN (2010) Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics 7: 543–564 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Uversky VN (2011) Multitude of binding modes attainable by intrinsically disordered proteins: a portrait gallery of disorder-based complexes. Chem Soc Rev 40: 1623–1634 [DOI] [PubMed] [Google Scholar]
- 42.Crawford LJ, Walker B, Irvine AE (2011) Proteasome inhibitors in cancer therapy. J Cell Commun Signal 5: 101–110 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.